Junín virus infection activates the type I interferon pathway in a RIG-I-dependent manner

Cheng Huang, Olga A. Kolokoltsova, Nadezdha E. Yun, Alexey V. Seregin, Allison L. Poussard, Aida G. Walker, Allan R. Brasier, Yingxin Zhao, Bing Tian, Juan Carlos de la Torre, Slobodan Paessler

Research output: Contribution to journalArticle

38 Citations (Scopus)

Abstract

Junín virus (JUNV), an arenavirus, is the causative agent of Argentine hemorrhagic fever, an infectious human disease with 15-30% case fatality. The pathogenesis of AHF is still not well understood. Elevated levels of interferon and cytokines are reported in AHF patients, which might be correlated to the severity of the disease. However the innate immune response to JUNV infection has not been well evaluated. Previous studies have suggested that the virulent strain of JUNV does not induce IFN in human macrophages and monocytes, whereas the attenuated strain of JUNV was found to induce IFN response in murine macrophages via the TLR-2 signaling pathway. In this study, we investigated the interaction between JUNV and IFN pathway in human epithelial cells highly permissive to JUNV infection. We have determined the expression pattern of interferon-stimulated genes (ISGs) and IFN-β at both mRNA and protein levels during JUNV infection. Our results clearly indicate that JUNV infection activates the type I IFN response. STAT1 phosphorylation, a downstream marker of activation of IFN signaling pathway, was readily detected in JUNV infected IFN-competent cells. Our studies also demonstrated for the first time that RIG-I was required for IFN production during JUNV infection. IFN activation was detected during infection by either the virulent or attenuated vaccine strain of JUNV. Curiously, both virus strains were relatively insensitive to human IFN treatment. Our studies collectively indicated that JUNV infection could induce host type I IFN response and provided new insights into the interaction between JUNV and host innate immune system, which might be important in future studies on vaccine development and antiviral treatment.

Original languageEnglish (US)
Article numbere1659
JournalPLoS Neglected Tropical Diseases
Volume6
Issue number5
DOIs
StatePublished - May 2012

Fingerprint

Interferon Type I
Virus Diseases
Viruses
Interferons
Arenavirus
Macrophages
Attenuated Vaccines
Innate Immunity
Antiviral Agents
Communicable Diseases
Monocytes
Immune System
Fever
Vaccines
Epithelial Cells
Phosphorylation
Cytokines
Messenger RNA
Therapeutics
Infection

ASJC Scopus subject areas

  • Infectious Diseases
  • Public Health, Environmental and Occupational Health
  • Pharmacology, Toxicology and Pharmaceutics(all)

Cite this

Junín virus infection activates the type I interferon pathway in a RIG-I-dependent manner. / Huang, Cheng; Kolokoltsova, Olga A.; Yun, Nadezdha E.; Seregin, Alexey V.; Poussard, Allison L.; Walker, Aida G.; Brasier, Allan R.; Zhao, Yingxin; Tian, Bing; de la Torre, Juan Carlos; Paessler, Slobodan.

In: PLoS Neglected Tropical Diseases, Vol. 6, No. 5, e1659, 05.2012.

Research output: Contribution to journalArticle

Huang, Cheng ; Kolokoltsova, Olga A. ; Yun, Nadezdha E. ; Seregin, Alexey V. ; Poussard, Allison L. ; Walker, Aida G. ; Brasier, Allan R. ; Zhao, Yingxin ; Tian, Bing ; de la Torre, Juan Carlos ; Paessler, Slobodan. / Junín virus infection activates the type I interferon pathway in a RIG-I-dependent manner. In: PLoS Neglected Tropical Diseases. 2012 ; Vol. 6, No. 5.
@article{dbc18f4853b8442bb0a63438b1a65777,
title = "Jun{\'i}n virus infection activates the type I interferon pathway in a RIG-I-dependent manner",
abstract = "Jun{\'i}n virus (JUNV), an arenavirus, is the causative agent of Argentine hemorrhagic fever, an infectious human disease with 15-30{\%} case fatality. The pathogenesis of AHF is still not well understood. Elevated levels of interferon and cytokines are reported in AHF patients, which might be correlated to the severity of the disease. However the innate immune response to JUNV infection has not been well evaluated. Previous studies have suggested that the virulent strain of JUNV does not induce IFN in human macrophages and monocytes, whereas the attenuated strain of JUNV was found to induce IFN response in murine macrophages via the TLR-2 signaling pathway. In this study, we investigated the interaction between JUNV and IFN pathway in human epithelial cells highly permissive to JUNV infection. We have determined the expression pattern of interferon-stimulated genes (ISGs) and IFN-β at both mRNA and protein levels during JUNV infection. Our results clearly indicate that JUNV infection activates the type I IFN response. STAT1 phosphorylation, a downstream marker of activation of IFN signaling pathway, was readily detected in JUNV infected IFN-competent cells. Our studies also demonstrated for the first time that RIG-I was required for IFN production during JUNV infection. IFN activation was detected during infection by either the virulent or attenuated vaccine strain of JUNV. Curiously, both virus strains were relatively insensitive to human IFN treatment. Our studies collectively indicated that JUNV infection could induce host type I IFN response and provided new insights into the interaction between JUNV and host innate immune system, which might be important in future studies on vaccine development and antiviral treatment.",
author = "Cheng Huang and Kolokoltsova, {Olga A.} and Yun, {Nadezdha E.} and Seregin, {Alexey V.} and Poussard, {Allison L.} and Walker, {Aida G.} and Brasier, {Allan R.} and Yingxin Zhao and Bing Tian and {de la Torre}, {Juan Carlos} and Slobodan Paessler",
year = "2012",
month = "5",
doi = "10.1371/journal.pntd.0001659",
language = "English (US)",
volume = "6",
journal = "PLoS Neglected Tropical Diseases",
issn = "1935-2727",
publisher = "Public Library of Science",
number = "5",

}

TY - JOUR

T1 - Junín virus infection activates the type I interferon pathway in a RIG-I-dependent manner

AU - Huang, Cheng

AU - Kolokoltsova, Olga A.

AU - Yun, Nadezdha E.

AU - Seregin, Alexey V.

AU - Poussard, Allison L.

AU - Walker, Aida G.

AU - Brasier, Allan R.

AU - Zhao, Yingxin

AU - Tian, Bing

AU - de la Torre, Juan Carlos

AU - Paessler, Slobodan

PY - 2012/5

Y1 - 2012/5

N2 - Junín virus (JUNV), an arenavirus, is the causative agent of Argentine hemorrhagic fever, an infectious human disease with 15-30% case fatality. The pathogenesis of AHF is still not well understood. Elevated levels of interferon and cytokines are reported in AHF patients, which might be correlated to the severity of the disease. However the innate immune response to JUNV infection has not been well evaluated. Previous studies have suggested that the virulent strain of JUNV does not induce IFN in human macrophages and monocytes, whereas the attenuated strain of JUNV was found to induce IFN response in murine macrophages via the TLR-2 signaling pathway. In this study, we investigated the interaction between JUNV and IFN pathway in human epithelial cells highly permissive to JUNV infection. We have determined the expression pattern of interferon-stimulated genes (ISGs) and IFN-β at both mRNA and protein levels during JUNV infection. Our results clearly indicate that JUNV infection activates the type I IFN response. STAT1 phosphorylation, a downstream marker of activation of IFN signaling pathway, was readily detected in JUNV infected IFN-competent cells. Our studies also demonstrated for the first time that RIG-I was required for IFN production during JUNV infection. IFN activation was detected during infection by either the virulent or attenuated vaccine strain of JUNV. Curiously, both virus strains were relatively insensitive to human IFN treatment. Our studies collectively indicated that JUNV infection could induce host type I IFN response and provided new insights into the interaction between JUNV and host innate immune system, which might be important in future studies on vaccine development and antiviral treatment.

AB - Junín virus (JUNV), an arenavirus, is the causative agent of Argentine hemorrhagic fever, an infectious human disease with 15-30% case fatality. The pathogenesis of AHF is still not well understood. Elevated levels of interferon and cytokines are reported in AHF patients, which might be correlated to the severity of the disease. However the innate immune response to JUNV infection has not been well evaluated. Previous studies have suggested that the virulent strain of JUNV does not induce IFN in human macrophages and monocytes, whereas the attenuated strain of JUNV was found to induce IFN response in murine macrophages via the TLR-2 signaling pathway. In this study, we investigated the interaction between JUNV and IFN pathway in human epithelial cells highly permissive to JUNV infection. We have determined the expression pattern of interferon-stimulated genes (ISGs) and IFN-β at both mRNA and protein levels during JUNV infection. Our results clearly indicate that JUNV infection activates the type I IFN response. STAT1 phosphorylation, a downstream marker of activation of IFN signaling pathway, was readily detected in JUNV infected IFN-competent cells. Our studies also demonstrated for the first time that RIG-I was required for IFN production during JUNV infection. IFN activation was detected during infection by either the virulent or attenuated vaccine strain of JUNV. Curiously, both virus strains were relatively insensitive to human IFN treatment. Our studies collectively indicated that JUNV infection could induce host type I IFN response and provided new insights into the interaction between JUNV and host innate immune system, which might be important in future studies on vaccine development and antiviral treatment.

UR - http://www.scopus.com/inward/record.url?scp=84863698000&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84863698000&partnerID=8YFLogxK

U2 - 10.1371/journal.pntd.0001659

DO - 10.1371/journal.pntd.0001659

M3 - Article

VL - 6

JO - PLoS Neglected Tropical Diseases

JF - PLoS Neglected Tropical Diseases

SN - 1935-2727

IS - 5

M1 - e1659

ER -